GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
对氯乙烯诱发癌症的遗传易感性
基本信息
- 批准号:6043507
- 负责人:
- 金额:$ 21.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2001-03-31
- 项目状态:已结题
- 来源:
- 关键词:N glycosidase angiosarcoma biomarker chemical carcinogen chemical related neoplasm /cancer clinical research cytochrome P450 disease /disorder proneness /risk gene environment interaction genetic polymorphism genetic promoter element glutathione transferase human genetic material tag human subject liver neoplasms methylpurine neoplasm /cancer genetics nucleic acid sequence phenotype polymerase chain reaction polyvinyls single strand conformation polymorphism
项目摘要
DESCRIPTION (Adapted from the Investigator's Abstract): The long-term
objective of this research is to develop genetically-based biomarker assays
for identifying individuals with increased health-risk from exposure to
carcinogens. The specific objective is to identify genetic determinants of
vinyl chloride-metabolism and DNA lesion repair for use as biomarkers to
assess a priori susceptibility to vinyl chloride-induced liver cancer in
humans. Angiosarcoma of the liver (ASL) will be used as a working model.
ASL is a devastating disease with a 100% rate of mortality. There is a
strong association between ASL and occupational exposure to vinyl chloride
(VC). ASL occurs at a constant rate over a broad range of vinyl chloride
(VC) exposure, suggesting the existence of a high risk phenotype in humans.
The mutagenic potential of VC is controlled by three processes: 1) It is
increased by cytochrome P4502E1 (CYP2E1)-mediated bioactivation, 2) it is
decreased through glutathione S-transferase (GST)-mediated conjugation of
metabolites to glutathione, and, 3) it is decreased through methylpurine-DNA
glycosylase (MPG)-initiated removal of etheno-DNA adducts. The model is
well defined because it includes: a unique source of subjects exposed to
VC, liver tissue samples from subjects with ASL, a well characterized
VC-associated tumor cell line, the causative agent (VC and its metabolite),
and the likelihood of genetic susceptibility. The investigators hypothesize
that susceptibility to VC-induced angiosarcoma of the liver is associated
with genetic determinants of aberrant CYP2E1, GST and/or MPG phenotypes. To
evaluate this hypothesis, they will: 1) screen individuals with ASL for
specific mutations of the CYP2E1 and MPG genes which may lead to a high risk
phenotype; 2) develop methods to screen a human population for the
prevalence of CYP2E1 and MPG mutant alleles identified in ASL subjects, and,
3) determine the relationship between polymorphism in CYP2E1, GST, and/or
MPG and susceptibility to liver cancer in a population of individuals
exposed to vinyl chloride. This research is expected to provide a mechanism
to rapidly and effectively identify individuals currently working in the
vinyl monomer industry who may be at high risk for acquiring VC-induced ASL.
It will also provide a working model for assessing the role of CYP2E1, GST,
and MPG in exposure-linked health outcome. The results will provide a
genetic-based model useful in approaching a variety of other diseases caused
from environmental exposure to xenobiotics.
描述(改编自研究者摘要):长期
本研究的目的是开发基于遗传学的生物标志物检测方法
用于识别暴露于以下物质的健康风险增加的个人:
致癌物质。 具体目标是确定遗传决定因素,
氯乙烯代谢和DNA损伤修复作为生物标志物,
评估氯乙烯诱发肝癌的先验易感性,
人类 肝脏血管肉瘤(ASL)将用作工作模型。
ASL是一种毁灭性的疾病,死亡率为100%。 有一个
ASL与氯乙烯职业暴露之间的强相关性
(VC)。 ASL在很宽的氯乙烯范围内以恒定的速率发生
(VC)暴露,表明人类存在高风险表型。
VC的致突变潜力受三个过程控制:1)
细胞色素P4502 E1(CYP 2 E1)介导的生物活化增加,2)它是
通过谷胱甘肽S-转移酶(GST)介导的
代谢产物谷胱甘肽,和,3)它是减少通过甲基嘌呤-DNA
糖基化酶(MPG)引发的乙烯基-DNA加合物的去除。 该模型
定义明确,因为它包括:一个独特的受试者来源,
VC,来自ASL受试者的肝组织样本,
VC相关肿瘤细胞系,致病因子(VC及其代谢产物),
和遗传易感性的可能性。 调查人员假设
对VC诱导的肝脏血管肉瘤的易感性与
具有异常CYP 2 E1、GST和/或MPG表型的遗传决定因素。 到
为了评估这一假设,他们将:1)筛选ASL患者,
CYP 2 E1和MPG基因的特定突变可能导致高风险
表型; 2)开发筛选人类群体的方法,
ASL受试者中确定的CYP 2 E1和MPG突变等位基因的患病率,以及,
3)确定CYP 2 E1、GST和/或
MPG与个体人群肝癌易感性
暴露在氯乙烯中 这项研究有望提供一种机制,
迅速有效地查明目前在
乙烯基单体行业,他们可能处于获得VC诱导ASL的高风险中。
它还将为评估CYP 2 E1,GST,
和MPG在与糖尿病相关的健康结果中的作用。 结果将提供一个
基于遗传学的模型,可用于处理各种其他疾病引起的
从环境暴露到异生物质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roland Valdes其他文献
Roland Valdes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roland Valdes', 18)}}的其他基金
A Non-invasive Assay for Obstructive Sleep Apnea
阻塞性睡眠呼吸暂停的无创检测
- 批准号:
9408287 - 财政年份:2017
- 资助金额:
$ 21.84万 - 项目类别:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
对氯乙烯诱发癌症的遗传易感性
- 批准号:
6353828 - 财政年份:1997
- 资助金额:
$ 21.84万 - 项目类别:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
对氯乙烯诱发癌症的遗传易感性
- 批准号:
2749712 - 财政年份:1997
- 资助金额:
$ 21.84万 - 项目类别:
GENETIC SUSCEPTIBILITY TO VINYL CHLORIDE INDUCED CANCER
对氯乙烯诱发癌症的遗传易感性
- 批准号:
2378004 - 财政年份:1997
- 资助金额:
$ 21.84万 - 项目类别:
ENDOGENOUS DIGOXIN-IMMUNOACTIVITY IN HYPERTENSIVE PREGNA
妊娠期高血压患者的内源性地高辛免疫活性
- 批准号:
3352632 - 财政年份:1989
- 资助金额:
$ 21.84万 - 项目类别:
CHARACTERIZATION OF HUMAN ENDOGENOUS DIGOXIN-LIKE FACTOR
人内源性地高辛样因子的表征
- 批准号:
3350922 - 财政年份:1989
- 资助金额:
$ 21.84万 - 项目类别:
相似海外基金
Development of a novel therapeutic strategy for angiosarcoma through drug screening
通过药物筛选开发血管肉瘤新治疗策略
- 批准号:
23K07757 - 财政年份:2023
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PAI-1 promotes angiogenesis in cutaneous angiosarcoma
PAI-1促进皮肤血管肉瘤的血管生成
- 批准号:
23K15260 - 财政年份:2023
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of therapeutic strategies for angiosarcoma of the scalp and face based on genome-wide analysis of tumor somatic mutation pattern
基于肿瘤体细胞突变模式的全基因组分析开发头皮和面部血管肉瘤的治疗策略
- 批准号:
20K17323 - 财政年份:2020
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Endoglin as therapeutic target in angiosarcoma.
内皮糖蛋白作为血管肉瘤的治疗靶点。
- 批准号:
20K08675 - 财政年份:2020
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The efficacy of VEGFR inhibitor and anti-IL-17 antibody for angiosarcoma
VEGFR抑制剂和抗IL-17抗体治疗血管肉瘤的疗效
- 批准号:
19K17785 - 财政年份:2019
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Detection of tumor-specific antigen of highly prevalent angiosarcoma in Okinawa by comprehensive transcriptome analysis
通过综合转录组分析检测冲绳高发血管肉瘤的肿瘤特异性抗原
- 批准号:
19K21277 - 财政年份:2018
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Basic research on radiotherapy of angiosarcoma
血管肉瘤放射治疗的基础研究
- 批准号:
17K10498 - 财政年份:2017
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The effect of HSP 90 inhibition for angiosarcoma
HSP 90 抑制对血管肉瘤的作用
- 批准号:
16K19728 - 财政年份:2016
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The effect of PI3K pathway inhibitor and chemical epigenetics in angiosarcoma cells
PI3K通路抑制剂及化学表观遗传学对血管肉瘤细胞的影响
- 批准号:
16K19735 - 财政年份:2016
- 资助金额:
$ 21.84万 - 项目类别:
Grant-in-Aid for Young Scientists (B)